Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.

Zhitongcaijing · 4d ago
Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.